Glipizide recalls
The FDA has published 7 recalls involving Glipizide since 2015. The latest was reported on 27 Oct 2021. Most were for potency & assay. American Health Packaging has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls7since 2015
Last 12 months0reported
Class I00% of total
Ongoing0latest 27 Oct 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 6 86%Class III 1 14%
Why glipizide is recalled
Companies
By year
All glipizide recalls, newest first
7 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | GlipiZIDE Extended-Release Tablets, 5 mg recalled | American Health Packaging | Potency & Assay | Nationwide |
| Drug | CLASS II | GlipiZIDE Extended-release Tablets, 5 mg (3 x recalled | American Health Packaging | Potency & Assay | Nationwide |
| Drug | CLASS III | Glipizide Extended-Release Tablets (anti-diabetic agent), 5 mg recalled | Teva Pharmaceuticals U | Potency & Assay | 6 states |
| Drug | CLASS II | GlipiZIDE Extended-release tablets, 5 mg carton recalled | Amerisource Health Services | Potency & Assay | Nationwide |
| Drug | CLASS II | glipiZIDE Extended-Release Tablets, 5 mg recalled | Mylan Pharmaceuticals | Other | Nationwide |
| Drug | CLASS II | Glipizide extended-release tablets, 5mg recalled by Actavis | Actavis | Potency & Assay | Nationwide |
| Drug | CLASS II | Glipizide and Metformin Hydrochloride Tablets, USP, 5 mg/500 mg recalledGlipizide And Metformin Hcl | Heritage Pharmaceuticals | Potency & Assay | Nationwide |
Should you stop taking Glipizide?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.